Friday's top analyst upgrades and downgrades included Bill.com, CenterPoint Energy, CommScope, Herbalife, Hyatt Hotels, Motorola Solutions, Murphy Oil, Trade Desk and Vonage.
Monday's top analyst upgrades, downgrades and initiations included ABB, Apple, Baidu, Casper Sleep, General Electric, Groupon, JPMorgan, Micron Technology, PPD, Verizon Communications and Wayfair.
Tuesday's top analyst upgrades, downgrades and initiations included AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack and T-Mobile.
Friday's top analyst upgrades, downgrades and initiations included Agilent Technologies, Alphabet, Altria, Amazon.com, Boeing, Caterpillar, Chipotle Mexican Grill, E*Trade, Gap, Snap and Twitter.
The top analyst upgrades, downgrades and other research calls from Tuesday include Applied Materials, BioCryst, Costco, Generac, Goodyear, Intel, Microsoft and Netflix.
The top analyst upgrades, downgrades and other research calls from Monday include Apple, BHP Billiton, CBS, Eli Lilly, GE, Halliburton, IBM, Schlumberger and Verizon.
According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown to offer growth at a reasonable price.
The contract research organizations, or CROs, may offer a lot of value as companies look to bring in help from the outside in drug studies and development.
Jon C. Ogg The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Coeur Mining, Laredo Petroleum, Marathon Oil, Nike and Statoil.
In a new research report, Jefferies analysts focus in on three blue chips stocks rated Buy that they feel have the potential to beat current second-quarter earnings expectations.
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Broadcom, Caterpillar, Sirius XM, Newmont, Palo Alto, Perrigo, Sarepta and Xerox.
Monday’s top analyst upgrades, downgrades and initiations include EMC, Goldman Sachs, Linn Energy, MGIC, Marvell Technology and NetApp.
Credit Suisse assumed coverage with handy upside in the CRO leaders, and on average the firm is calling for upside of about 15%.
The analysts at Cowen have calculated the buys and sells in the NYSE Arca Biotechnology Index based on the holdings in the First Trust Biotechnology ETF.
Friday's top analyst upgrades, downgrades and initiations include AT&T, Costco, Gap, Intercontinental Exchange, Rackspace, Sprint, Verizon Communications and Weatherford International.
